Volpe Umberto, Vignapiano Annarita, Gallo Olimpia, Fabrazzo Michele
Department of Psychiatry, University of Naples SUN, Naples, Italy.
BMJ Case Rep. 2014 Oct 21;2014:bcr2014205805. doi: 10.1136/bcr-2014-205805.
Anecdotal evidence tends to favour olanzapine in the treatment of hallucinations in patients with schizophrenia spectrum disorders; however, no conclusive evidence is available on this topic. We report here a clinical case in which a 46-year-old man, suffering from a schizoaffective disorder (depressed type), underwent olanzapine treatment (20 mg/day). After inducing an initial amelioration, the patient had a re-exacerbation of auditory hallucinations and a clinical and psychosocial worsening, which subsided after olanzapine discontinuation. Olanzapine may induce a worsening of hallucinations in a psychotic disorder with substantial affective component and therefore its use should be carefully evaluated in such cases.
轶事证据倾向于支持奥氮平治疗精神分裂症谱系障碍患者的幻觉;然而,关于这一主题尚无确凿证据。我们在此报告一例临床病例,一名46岁患有分裂情感障碍(抑郁型)的男性接受了奥氮平治疗(20毫克/天)。在最初症状改善后,患者出现幻听再次加重以及临床和社会心理状况恶化,在停用奥氮平后这些症状缓解。奥氮平可能会使具有显著情感成分的精神障碍中的幻觉恶化,因此在这类病例中使用时应仔细评估。